Opinion: The business case for investing in neglected tropical diseases

The lack of resources dedicated to reducing the neglected tropical diseases, or NTDs, burden across the world is resounding, but elimination of these diseases could be one of the best returns on investment available.

With lack of prioritization from the private sector, international donors have generally funded efforts to combat NTDs. The donor landscape, however, is increasingly difficult to predict against a backdrop of global instability, and countries affected by NTDs must employ financing solutions to protect the progress made to date and, crucially, to expand elimination successes to other NTDs and geographies.